Operating
Intellectual property agreement accrual
Edwards Lifesciences Intellectual property agreement accrual decreased by 237.8% to -$50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 36.2%, from -$36.7M to -$50M. Over 4 years (FY 2021 to FY 2025), Intellectual property agreement accrual shows a downward trend with a 27.2% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2018
Last reportedQ1 2026May 6, 2026
How to read this metric
An increase in accruals suggests future cash outflows, while a decrease indicates the settlement of these obligations.
Detailed definition
This metric captures the impact of accruals related to intellectual property agreements or legal settlements on operatin...
Peer comparison
Highly specific to companies with significant R&D and patent portfolios.
Metric ID:
operating_increase_decrease_in_legal_settlement_accrualHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.1M | -$22.8M | -$10.1M | -$10M | -$9.7M | -$16.4M | -$8.9M | $29.3M | -$43.8M | -$11.5M | -$7M | -$5.2M | -$6.6M | -$12.5M | -$12.5M | -$36.7M | -$12.5M | -$12.5M | -$14.8M | -$50M |
| QoQ Change | — | <-999% | +55.7% | +1.0% | +3.0% | -69.1% | +45.7% | +429.2% | -249.5% | +73.7% | +39.1% | +25.7% | -26.9% | -89.4% | +0.0% | -193.6% | +65.9% | +0.0% | -18.4% | -237.8% |
| YoY Change | — | — | — | — | -561.9% | +28.1% | +11.9% | +393.0% | -351.5% | +29.9% | +21.3% | -117.7% | +84.9% | -8.7% | -78.6% | -605.8% | -89.4% | +0.0% | -18.4% | -36.2% |
Range-$50M – $29.3M
CAGR+94.9%
Avg YoY Growth-81.2%
Median YoY Growth-13.5%
Current Streak2 quarters decline
Intellectual property agreement accrual at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's intellectual property agreement accrual?
- Edwards Lifesciences (EW) reported intellectual property agreement accrual of -$50M in Q1 2026.
- How has Edwards Lifesciences's intellectual property agreement accrual changed year-over-year?
- Edwards Lifesciences's intellectual property agreement accrual decreased by 36.2% year-over-year, from -$36.7M to -$50M.
- What is the long-term trend for Edwards Lifesciences's intellectual property agreement accrual?
- Over 4 years (2021 to 2025), Edwards Lifesciences's intellectual property agreement accrual has grown at a 27.2% compound annual growth rate (CAGR), from -$29.2M to -$76.5M.
- What does intellectual property agreement accrual mean?
- The net change in cash obligations related to intellectual property or legal settlements.